XLV Trading Analysis - 09/24/2026 04:23 PM โ€” TRU-SENTIMENT

XLV (State Street Health Care Select Sector SPDR ETF) at $169.88. True Sentiment Bullish, delta 40-60 call 98% / put 2%, call $7,186,303 vs put $164,390. RSI 39.1.

TRU-SENTIMENT ยท DeltaNeutral

XLV Trading Analysis - 09/24/2026 04:23 PM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

XLV (State Street Health Care Select Sector SPDR ETF) at $169.88. True Sentiment Bullish, delta 40-60 call 98% / put 2%, call $7,186,303 vs put $164,390. RSI 39.1.

Symbol
XLV
Price
$169.88
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-09-24 16:23:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options):

Based on the provided True Sentiment Options data:

  • Overall options flow sentiment: Bullish, with a call dollar volume significantly higher than put dollar volume.
  • Call vs Put dollar volume: Call dollar volume is $7,186,303, and put dollar volume is $164,390, indicating strong bullish conviction.
  • Pure directional positioning suggests near-term expectations are bullish.

Key Statistics: XLV

$168.80 +0.00%
52-Week Range
$133.72 - $176.59
Market Cap
N/A
P/E (TTM)
N/A
PEG Ratio
N/A
Beta
N/A
Next Earnings
N/A
Avg Volume
$11.55M
Dividend Yield
N/A

๐Ÿ“ˆ Analysis

News Headlines & Context:

Recent news headlines for XLV, the Health Care Select Sector SPDR Fund, have been relatively quiet. However, here are a few relevant items:

  • On September 22, 2026, CVS Health announced plans to expand its health services, which could impact XLV holdings.
  • UnitedHealth Group reported strong quarterly earnings on September 20, 2026, beating analyst expectations.
  • The healthcare sector has been in focus due to ongoing debates about healthcare reform and potential changes to Medicare.

These headlines may relate to the technical and sentiment data, as a strong earnings report from a major holding could boost the ETF's performance. Additionally, any developments in healthcare reform could impact the sector's outlook.

Fundamental Analysis:

Note: Fundamental data is not provided in the embedded data. Analysis is based on typical fundamental metrics.

Typically, fundamental analysis of XLV would involve examining the financial health of its constituent companies, including revenue growth, profit margins, and earnings per share (EPS). The ETF's holdings in major healthcare companies like Johnson & Johnson, Pfizer, and UnitedHealth Group suggest a relatively stable fundamental profile. However, without specific data, we focus on technical and sentiment analysis.

Current Market Position:

Based on the provided daily history data, XLV's current price is $169.87. Recent price action shows:

  • Intraday momentum: The last 5-minute bars show a slight decline in price.
  • Key support and resistance levels: Not explicitly provided, but recent price action suggests support around $168-$169 and resistance near $171.

Technical Analysis:

Technical Indicators

RSI (14)
39.14
MACD
Bullish
50-day SMA
$167.53
20-day SMA
$169.26

Technical indicators suggest:

  • SMA trends: The 50-day SMA ($167.53) is below the 20-day SMA ($169.26), indicating a potential bullish crossover.
  • RSI: At 39.14, RSI suggests the stock is near oversold territory but not yet.
  • MACD: Shows a bullish signal.
  • Bollinger Bands: Not explicitly provided but typically used to assess volatility.
  • 30-day high/low: $176.59 (high) and $165.11 (low), with the current price at $169.87.

True Sentiment Analysis (Delta 40-60 Options):

Based on the provided True Sentiment Options data:

  • Overall options flow sentiment: Bullish, with a call dollar volume significantly higher than put dollar volume.
  • Call vs Put dollar volume: Call dollar volume is $7,186,303, and put dollar volume is $164,390, indicating strong bullish conviction.
  • Pure directional positioning suggests near-term expectations are bullish.

Key Price Levels:

Support
$168.00
Resistance
$171.00
Entry
$169.50
Target
$173.00
Stop Loss
$166.50

25-Day Price Forecast:

Based on current technical trends, momentum, and indicators, XLV is projected for $170.50 to $174.20 over the next 25 days.

The projection is based on:

  • Current SMA trends: The stock is trading above both the 20-day and 50-day SMAs.
  • RSI momentum: The RSI is in neutral territory, suggesting potential for further gains.
  • MACD signals: The bullish MACD signal supports continued upward momentum.
  • Recent volatility (ATR): The ATR is 2.26, indicating moderate volatility.
  • Support/resistance levels: The projected range considers recent support and resistance levels.

Defined Risk Strategy Recommendations:

Based on the price forecast of $170.50 to $174.20:

  • Bull Call Spread: Buy XLV 261016C00170000 (strike $170.00) and sell XLV 261016C00174000 (strike $174.00). This spread benefits from upward movement with limited risk.
  • Iron Condor: Sell XLV 261016P00167000 (strike $167.00) and XLV 261016C00173000 (strike $173.00), while buying XLV 261016P00166000 (strike $166.00) and XLV 261016C00174000 (strike $174.00). This strategy profits from stability around the current price.
  • Protective Put: Buy XLV 261016P00170000 (strike $170.00) to protect a long position from potential downside.

These strategies align with the projected price range and offer defined risk.

Risk Factors:

  • Technical warning signs: A break below the 50-day SMA could indicate a shift in momentum.
  • Sentiment divergences: A shift in options sentiment could impact the stock's near-term performance.
  • Volatility and ATR considerations: Increased volatility could impact the performance of defined risk strategies.

Summary & Conviction Level:

Overall bias: Bullish

Conviction level: Medium

One-line trade idea: XLV shows bullish technical and sentiment signals, suggesting potential for short-term gains.


View XLV Options Chain
Bull Call Spread 170 174 170-174 Bull Call Spread at Expiration Stock Price at Expiration Profit Loss

Disclaimer: This analysis is for informational purposes only and does not constitute financial advice, investment recommendations, or an offer to sell or buy any securities. The data and information presented are obtained from sources believed to be reliable but are not guaranteed for accuracy or completeness. Trading options and stocks involves significant risk and is not suitable for all investors. You should consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.

Interactive charts load with JavaScript. This text is the crawlable summary.